Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FP-020 by Foresee Pharmaceuticals for Sarcoidosis: Likelihood of Approval
FP-020 is under clinical development by Foresee Pharmaceuticals and currently in Phase I for Sarcoidosis. According to GlobalData, Phase I...